Osako T - Search Results

1

Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment.

Miyata K, Zhou X, Nishio M, Hanyu A, Chiba M, Kawasaki H, Osako T, Takeuchi K, Ohno S, Ueno T, Maruyama R, Takahashi A. Miyata K, et al. Among authors: osako t. Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2305046120. doi: 10.1073/pnas.2305046120. Epub 2023 Jul 31. Proc Natl Acad Sci U S A. 2023. PMID: 37523559 Free PMC article.

2

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.

Saeki S, Kumegawa K, Takahashi Y, Yang L, Osako T, Yasen M, Otsuji K, Miyata K, Yamakawa K, Suzuka J, Sakimoto Y, Ozaki Y, Takano T, Sano T, Noda T, Ohno S, Yao R, Ueno T, Maruyama R. Saeki S, et al. Among authors: osako t. Breast Cancer Res. 2023 Feb 21;25(1):21. doi: 10.1186/s13058-023-01617-4. Breast Cancer Res. 2023. PMID: 36810117 Free PMC article.

3

Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.

Kikuchi M, Gomi N, Ueki A, Osako T, Terauchi T. Kikuchi M, et al. Among authors: osako t. Breast Cancer. 2023 Jul;30(4):577-583. doi: 10.1007/s12282-023-01448-3. Epub 2023 Mar 10. Breast Cancer. 2023. PMID: 36897545

4

Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest^™ 95GC Breast in a multi‑institutional registry study.

Naoi Y, Tsunashima R, Shimazu K, Oikawa M, Imanishi S, Koyama H, Kamada Y, Ishihara K, Suzuki M, Osako T, Kinoshita T, Suto A, Nakamura S, Tsuda H, Noguchi S. Naoi Y, et al. Among authors: osako t. Oncol Lett. 2023 Apr 5;25(5):209. doi: 10.3892/ol.2023.13794. eCollection 2023 May. Oncol Lett. 2023. PMID: 37123024 Free PMC article.

5

Overall survival in Japanese patients with ER+/HER2- advanced breast cancer treated with first-line palbociclib plus letrozole.

Takahashi M, Osako T, Yasojima H, Inoue K, Kawashima M, Maeda H, Ichikawa A, Muramatsu Y, Masuda N. Takahashi M, et al. Among authors: osako t. Breast Cancer. 2024 Jan;31(1):53-62. doi: 10.1007/s12282-023-01511-z. Epub 2023 Oct 26. Breast Cancer. 2024. PMID: 37882974 Free PMC article.

6

Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III.

Takano T, Ito M, Kadoya T, Osako T, Aruga T, Masuda N, Miyaki T, Niikura N, Shimizu D, Yokoyama Y, Watanabe M, Tomomitsu M, Aogi K. Takano T, et al. Among authors: osako t. Cancer Med. 2023 Oct;12(20):20242-20250. doi: 10.1002/cam4.6519. Epub 2023 Oct 12. Cancer Med. 2023. PMID: 37824431 Free PMC article. Clinical Trial.

7

Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer.

Mizoguchi K, Kawaji H, Kai M, Morisaki T, Hayashi S, Takao Y, Yamada M, Shimazaki A, Osako T, Arima N, Okido M, Oda Y, Nakamura M, Kubo M. Mizoguchi K, et al. Among authors: osako t. Cancers (Basel). 2023 Sep 7;15(18):4456. doi: 10.3390/cancers15184456. Cancers (Basel). 2023. PMID: 37760424 Free PMC article.

8

Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.

Kumegawa K, Saeki S, Takahashi Y, Yang L, Osako T, Nakadai T, Amino S, Maeda T, Takahata C, Mori S, Noda T, Ohno S, Ueno T, Maruyama R. Kumegawa K, et al. Among authors: osako t. Br J Cancer. 2023 Mar;128(7):1400-1404. doi: 10.1038/s41416-023-02206-0. Br J Cancer. 2023. PMID: 36914723 Free PMC article. No abstract available.

9

Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.

Kumegawa K, Saeki S, Takahashi Y, Yang L, Osako T, Nakadai T, Amino S, Maeda T, Takahata C, Mori S, Noda T, Ohno S, Ueno T, Maruyama R. Kumegawa K, et al. Among authors: osako t. Br J Cancer. 2023 Mar;128(7):1208-1222. doi: 10.1038/s41416-023-02178-1. Epub 2023 Feb 1. Br J Cancer. 2023. PMID: 36725920 Free PMC article.

10

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.

Inoue Y, Fujishima M, Ono M, Masuda J, Ozaki Y, Maeda T, Uehiro N, Takahashi Y, Kobayashi T, Sakai T, Osako T, Ueno T, Ohno S. Inoue Y, et al. Among authors: osako t. Breast Cancer Res Treat. 2022 Nov;196(2):341-348. doi: 10.1007/s10549-022-06726-w. Epub 2022 Sep 24. Breast Cancer Res Treat. 2022. PMID: 36153381 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page